Jon Ogg

Jon Ogg is co-founder and editor for 24/7 Wall St.

Jon has worked as a news analyst for nearly 10 years and also has experience as a broker, portfolio manager and investment adviser. He has been sourced for articles in CBS MarketWatch, E*Trade, TradeTheNews, FlyOnTheWall, Pristine, Evolution Trading, Knova Trading, Hammerstone, CNet.com, Seeking Alpha, Google Finance and other sites.

Prior to 24/7 Wall St., he formed News Contrast and was the founder of a service for active traders called TradeTheNews (which he sold in 2003) and built up a news desk that was merged into E*Trade. He also worked in Copenhagen, Denmark as a portfolio manager for European clients trading U.S. equities and ran the event-driven trading team there.

He has been a financial adviser and has advised start-up and emerging-stage companies, and started his career as a licensed broker selling fixed income to some of the largest investment managers in the United States. He received a B.B.A. in Finance from the University of Houston (1992).

Jon does not hold any positions in any stocks he writes about.

Recent Articles

Oil & Gas ETF Volume Holds Up as Summer Ends

Two controversial ETF and ETN products in commodities are the United States Natural Gas (NYSE: UNG) ETF and the United States Oil (NYSE: USO) ETF. These ETFs are supposed to track the natural gas markets and crude oil markets.

Burger King Bid Already Peaked

If you're looking for value in a fast food stock, you'll have to look elsewhere.

The Cheapest Genzyme Buyout Trade

These speculative options are a great deal if Genzyme gets a higher offer.

Medco (MHS) – Changing Values for Changing Investor Base?

Medco Health Solutions Inc. (NYSE: MHS) is in a strange place in time right now. The healthcare company is potentially the subject of more cost crunching, and is supposed to be one of the best in its industry. The issue seems to concern the size of the company, rather than its valuations of the past.

M&A Deals in Focus for Wall Street’s Week Ahead

There is a ton of dirt happening in the world of M&A right now. There are many deals to watch and many deals that "may be" items to watch. Some are confirmed, some are pending, and some are merely speculated.